2023年Journal of Diabetes第3期中文导读  

Chinese introduction to Journal of Diabetes 2023,Issue 3

作　　者：J Diabetes编辑部 J Diabetes Editorial Office

机构地区：[1]不详

出　　处：《中华内分泌代谢杂志》2023年第4期368-371,共4页Chinese Journal of Endocrinology and Metabolism

摘　　要：论著/Original Article在无保险的糖尿病人群中,胰岛素和降糖药物的经济负担正在加重Exacerbation of financial burden of insulin and overall glucose-lowing medications among uninsured population with diabetes Yilu Lin1,Hui Shao2,Vivian Fonseca3,Lizheng Shi11Department of Health Policy and Management,School of Public Health and Tropical Medicine,Tulane University,New Orleans,Los Angeles;2Department of Pharmaceutical Outcomes and Policy,College of Pharmacy,University of Florida,Gainesville,Florida.

关 键 词：糖尿病人群 PHARMACY 降糖药物 

分 类 号：R587.1[医药卫生—内分泌]